Tango Therapeutics, Inc. · NASDAQ:TNGX
The Vanguard Group reported a 5.01% stake in Tango Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 5.01% stake in Tango Therapeutics, Inc., 6,750,977 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G).
- Stake
- 5.01%
- Shares
- 6,750,977
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.01% | 6,750,977 |
Source
Related
- Tango Therapeutics, Inc.
- The Vanguard Group
- Tango Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 14, 2026